News and Events

Benign nail condition linked to rare syndrome that greatly increases cancer risk

Researchers from CCR and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) discovered the presence of a benign nail abnormality may lead to the diagnosis of a rare inherited disorder that increases the risk of developing cancerous tumors. The study suggests conducting nail evaluation of affected patients and at-risk family members.

Aligned Blog: Building Community: Celebrating AANHPI Heritage Month

The COVID-19 pandemic highlighted an alarming trend in anti-Asian hate across the United States. To celebrate Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Heritage Month, Sonia A. Garcia, Ph.D., Scientific Diversity Program Manager in CCR's Office of Equity & Inclusion (OEI), highlights an NIH initiative created out of such adversity and shares the OEI's upcoming seminar series on advancing AANHPI folks into leadership positions.

New research identifies a protein essential to maintaining chromosomal stability

Researchers discovered how overproduction of a protein called CENP-A can lead to chromosomal abnormalities, which are found in many types of cancer.

New database of sarcoma cell line data will drive rare cancer research

CCR researchers have developed the largest publicly accessible sarcoma cell line database called Sarcoma CellMinerCDB. The tool merges previously available and new sarcoma cell line data that can be used to identify new therapeutic targets for these cancers.

Clinical trial researching combination therapy for solid tumors

A trial led by Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, is researching white blood cell gene therapy and vaccine therapy for certain metastatic cancers.

Three CCR researchers elected to the National Academy of Sciences

Steven A. Rosenberg, M.D, Ph.D., Chief of the Surgery Branch, Giorgio Trinchieri, M.D., Chief of the Laboratory of Integrative Cancer Immunology, and Sandra L. Wolin, M.D., Ph.D., Chief of the RNA Biology Laboratory, were elected as 2024 members of the National Academy of Sciences in recognition of their distinguished and continuing achievements in original research. The Academy is committed to furthering science in America, and its members are outstanding contributors to the international scientific community.

Clinical trial researching detection methods for multiple myeloma

A trial led by Elizabeth M. Hill, M.D., Assistant Research Physician in the Lymphoid Malignancies Branch, is studying a radiotracer that may be a useful detection method for multiple myeloma.

Aligned Blog: Celebrating National Minority Health Month: Improving Health Through Culture, Communities and Connections

To celebrate National Minority Health Month, Brenda Adjei, Ed.D., M.P.A., Associate Director of CCR's Office of Healthcare Delivery and Equity Research, expands on this year's theme, "Be the Source for Better Health," and highlights some CCR researchers striving to make cancer care more equitable.

Jung-Min Lee elected to the American Society for Clinical Investigation

Jung-Min Lee, M.D., Senior Investigator in the Women’s Malignancies Branch, was elected to the American Society for Clinical Investigation. The organization seeks to support scientific efforts, educational needs and clinical aspirations of physician-scientists to improve the health of all people. Lee was selected for her merit as an internationally recognized expert in ovarian cancer and for being a highly respected clinician and physician-scientist.

CCR researchers receive a range of HHS awards

Three CCR researchers received prestigious awards from the Department of Health and Human Services. They are being recognized for their excellence, dedication and achievements in their respective research fields.

Breadcrumb